Increased failure of budesonide MMX for ulcerative colitis during the COVID-19 pandemic: a population-based study
Therapeutic Advances in Gastroenterology
Published online on March 30, 2026
Abstract
Therapeutic Advances in Gastroenterology, Volume 19, January-December 2026.
Background:Corticosteroids induce remission in ulcerative colitis (UC) but are associated with adverse effects, including prednisone ⩾20 mg/day associated with serious COVID-19 outcomes.Objectives:To evaluate the risk of rescue prednisone use following ...
Background:Corticosteroids induce remission in ulcerative colitis (UC) but are associated with adverse effects, including prednisone ⩾20 mg/day associated with serious COVID-19 outcomes.Objectives:To evaluate the risk of rescue prednisone use following ...